Search

everythinglearnresearchcommunity

for

Search:↓

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Lactococcus lactis strain H61 may reduce some ageing symptoms.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.